BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23075394)

  • 21. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
    Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
    Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C
    Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible and endothelial nitric oxide synthase genes polymorphism in inflammatory bowel disease.
    Oliver J; Gómez-Garcia M; Vilchez JR; López-Nevot MA; Piñero A; Correro F; Nieto A; Martín J
    Tissue Antigens; 2006 Apr; 67(4):326-30. PubMed ID: 16634870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
    Fidder HH; Heijmans R; Chowers Y; Bar-Meir S; Avidan B; Pena AS; Crusius JB
    Int J Immunogenet; 2006 Apr; 33(2):81-5. PubMed ID: 16611251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
    Saibeni S; Spina L; Virgilio T; Folcioni A; Borsi G; de Franchis R; Cugno M; Vecchi M
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):976-81. PubMed ID: 18049167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the influence of two CD24 genetic variants in Crohn's disease and ulcerative colitis.
    Diaz-Gallo LM; Medrano LM; Gómez-García M; Cardeña C; Rodrigo L; Mendoza JL; Taxonera C; Nieto A; Alcain G; Cueto I; López-Nevot MA; Urcelay E; Martin J
    Hum Immunol; 2011 Oct; 72(10):969-72. PubMed ID: 21684315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of secretor status of ABO antigens by high-resolution melting analysis of rs601338 (428G > A).
    Soejima M; Koda Y
    Clin Chim Acta; 2021 Jun; 517():86-91. PubMed ID: 33667483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms.
    Repnik K; Potocnik U
    DNA Cell Biol; 2010 Oct; 29(10):603-10. PubMed ID: 20491567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DLG5 variants contribute to Crohn disease risk in a Canadian population.
    Newman WG; Gu X; Wintle RF; Liu X; van Oene M; Amos CI; Siminovitch KA
    Hum Mutat; 2006 Apr; 27(4):353-8. PubMed ID: 16450402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.
    Polgar N; Csongei V; Szabo M; Zambo V; Melegh BI; Sumegi K; Nagy G; Tulassay Z; Melegh B
    Int J Immunogenet; 2012 Jun; 39(3):247-52. PubMed ID: 22269120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease.
    Palmieri O; Latiano A; Salvatori E; Valvano MR; Bossa F; Latiano T; Corritore G; di Mauro L; Andriulli A; Annesec V
    Am J Gastroenterol; 2010 Jul; 105(7):1586-94. PubMed ID: 20125127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.
    Rupp C; Friedrich K; Folseraas T; Wannhoff A; Bode KA; Weiss KH; Schirmacher P; Sauer P; Stremmel W; Gotthardt DN
    Aliment Pharmacol Ther; 2014 Apr; 39(8):873-82. PubMed ID: 24612312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease.
    Khazen D; Jendoubi-Ayed S; Aleya WB; Sfar I; Mouelhi L; Matri S; Najjar T; Filali A; Gorgi Y; Abdallah TB; Ayed K
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):167-75. PubMed ID: 19212205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CREM gene is involved in genetic predisposition to inflammatory bowel disease in the Tunisian population.
    Bouzid D; Fourati H; Amouri A; Marques I; Abida O; Haddouk S; Ben Ayed M; Tahri N; Penha-Gonçalves C; Masmoudi H
    Hum Immunol; 2011 Dec; 72(12):1204-9. PubMed ID: 22019623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility.
    Martín MC; Martinez A; Mendoza JL; Taxonera C; Díaz-Rubio M; Fernández-Arquero M; de la Concha EG; Urcelay E
    Immunogenetics; 2007 Nov; 59(11):833-7. PubMed ID: 17955236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric intrinsic factor deficiency with combined GIF heterozygous mutations and FUT2 secretor variant.
    Chery C; Hehn A; Mrabet N; Oussalah A; Jeannesson E; Besseau C; Alberto JM; Gross I; Josse T; Gérard P; Guéant-Rodriguez RM; Freund JN; Devignes J; Bourgaud F; Peyrin-Biroulet L; Feillet F; Guéant JL
    Biochimie; 2013 May; 95(5):995-1001. PubMed ID: 23402911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease.
    Martín MC; Oliver J; Urcelay E; Orozco G; Gómez-Garcia M; López-Nevot MA; Piñero A; Brieva JA; de la Concha EG; Nieto A; Martín J
    Tissue Antigens; 2005 Oct; 66(4):314-7. PubMed ID: 16185327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease].
    Waterman M; Karban A; Nesher S; Weiss B; Shamir R; Eliakim R
    Harefuah; 2006 Nov; 145(11):789-92, 864. PubMed ID: 17183946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.